These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 24719095)

  • 21. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
    Laaris N; Good CH; Lupica CR
    Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina.
    Papadogkonaki S; Theodorakis Κ; Thermos K
    Exp Eye Res; 2019 Aug; 185():107694. PubMed ID: 31199905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
    Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of CB
    Joffre J; Yeh CC; Wong E; Thete M; Xu F; Zlatanova I; Lloyd E; Kobzik L; Legrand M; Hellman J
    J Immunol; 2020 Jun; 204(12):3339-3350. PubMed ID: 32385136
    [No Abstract]   [Full Text] [Related]  

  • 25. Δ
    Shum C; Dutan L; Annuario E; Warre-Cornish K; Taylor SE; Taylor RD; Andreae LC; Buckley NJ; Price J; Bhattacharyya S; Srivastava DP
    Mol Cell Neurosci; 2020 Mar; 103():103463. PubMed ID: 31917333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabotropic suppression of excitation in murine autaptic hippocampal neurons.
    Straiker A; Mackie K
    J Physiol; 2007 Feb; 578(Pt 3):773-85. PubMed ID: 17110416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
    Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
    Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Leu/Val
    Llinas Del Torrent C; Raïch I; Gonzalez A; Casajuana-Martin N; Lillo J; Rebassa JB; Ferreiro-Vera C; Sánchez de Medina V; Franco R; Navarro G; Pardo L
    J Chem Inf Model; 2023 Sep; 63(18):5927-5935. PubMed ID: 37644761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay.
    Andersen HK; Vardakas DG; Lamothe JA; Perault TEA; Walsh KB; Laprairie RB
    Sci Rep; 2024 Aug; 14(1):18314. PubMed ID: 39112591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.
    Tai S; Hyatt WS; Gu C; Franks LN; Vasiljevik T; Brents LK; Prather PL; Fantegrossi WE
    Pharmacol Res; 2015 Dec; 102():22-32. PubMed ID: 26361728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade.
    Rubino T; Viganò D; Premoli F; Castiglioni C; Bianchessi S; Zippel R; Parolaro D
    Mol Neurobiol; 2006 Jun; 33(3):199-213. PubMed ID: 16954596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
    Sim-Selley LJ; Martin BR
    J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus.
    Guggenhuber S; Alpar A; Chen R; Schmitz N; Wickert M; Mattheus T; Harasta AE; Purrio M; Kaiser N; Elphick MR; Monory K; Kilb W; Luhmann HJ; Harkany T; Lutz B; Klugmann M
    Brain Struct Funct; 2016 May; 221(4):2061-74. PubMed ID: 25772509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain regional differences in CB1 receptor adaptation and regulation of transcription.
    Lazenka MF; Selley DE; Sim-Selley LJ
    Life Sci; 2013 Mar; 92(8-9):446-52. PubMed ID: 22940268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex, THC, and hormones: Effects on density and sensitivity of CB
    Farquhar CE; Breivogel CS; Gamage TF; Gay EA; Thomas BF; Craft RM; Wiley JL
    Drug Alcohol Depend; 2019 Jan; 194():20-27. PubMed ID: 30391834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of structurally novel G protein biased CB
    Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL
    Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
    Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
    Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors.
    Wu DF; Yang LQ; Goschke A; Stumm R; Brandenburg LO; Liang YJ; Höllt V; Koch T
    J Neurochem; 2008 Feb; 104(4):1132-43. PubMed ID: 17986216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential glutamatergic and GABAergic contributions to the tetrad effects of Δ
    De Giacomo V; Ruehle S; Lutz B; Häring M; Remmers F
    Neuropharmacology; 2020 Nov; 179():108287. PubMed ID: 32860777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice.
    Han X; Liang Y; Hempel B; Jordan CJ; Shen H; Bi GH; Li J; Xi ZX
    J Neurosci; 2023 Jan; 43(3):373-385. PubMed ID: 36517243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.